Defining the steps involved in a successful technology transfer process would benefit biopharma, say the researchers behind a “generic” blueprint intended to help drug makers move more easily from ...

Policy interventions, including large-scale private-public partnerships, are key to reducing prescription drug shortages and averting patient harm. Shortages of prescription generic drugs, which ...